Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more
Osteonic Co. Ltd (226400) - Net Assets
Latest net assets as of September 2025: ₩63.89 Billion KRW
Based on the latest financial reports, Osteonic Co. Ltd (226400) has net assets worth ₩63.89 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩96.14 Billion) and total liabilities (₩32.25 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩63.89 Billion |
| % of Total Assets | 66.46% |
| Annual Growth Rate | 28.18% |
| 5-Year Change | 144.32% |
| 10-Year Change | N/A |
| Growth Volatility | 90.34 |
Osteonic Co. Ltd - Net Assets Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Osteonic Co. Ltd (2015–2024)
The table below shows the annual net assets of Osteonic Co. Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩59.32 Billion | +14.36% |
| 2023-12-31 | ₩51.88 Billion | +42.13% |
| 2022-12-31 | ₩36.50 Billion | +2.73% |
| 2021-12-31 | ₩35.53 Billion | +46.33% |
| 2020-12-31 | ₩24.28 Billion | -16.15% |
| 2019-12-31 | ₩28.96 Billion | +1.61% |
| 2018-12-31 | ₩28.50 Billion | +283.72% |
| 2017-12-31 | ₩7.43 Billion | -36.40% |
| 2016-12-31 | ₩11.68 Billion | +83.97% |
| 2015-12-31 | ₩6.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Osteonic Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1679.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩10.33 Billion | 17.41% |
| Other Components | ₩56.86 Billion | 95.85% |
| Total Equity | ₩59.32 Billion | 100.00% |
Osteonic Co. Ltd Competitors by Market Cap
The table below lists competitors of Osteonic Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Elanders AB (publ)
ST:ELAN-B
|
$72.72 Million |
|
Krakatau Steel Persero Tbk
JK:KRAS
|
$72.78 Million |
|
OneSoft Solutions Inc
OTCQB:OSSIF
|
$72.80 Million |
|
Aifeex Nexus Acquisition Corporation
NASDAQ:AIFE
|
$72.80 Million |
|
Mercuries Data Systems Ltd
TW:2427
|
$72.68 Million |
|
Agro Tech Foods Limited
NSE:ATFL
|
$72.67 Million |
|
Waskita Karya Persero Tbk
JK:WSKT
|
$72.65 Million |
|
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
|
$72.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Osteonic Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 51,876,887,910 to 59,324,467,780, a change of 7,447,579,870 (14.4%).
- Net income of 5,649,607,030 contributed positively to equity growth.
- Other factors increased equity by 1,797,972,840.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩5.65 Billion | +9.52% |
| Other Changes | ₩1.80 Billion | +3.03% |
| Total Change | ₩- | 14.36% |
Book Value vs Market Value Analysis
This analysis compares Osteonic Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.44x to 2.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1492.95 | ₩6630.00 | x |
| 2017-12-31 | ₩949.44 | ₩6630.00 | x |
| 2018-12-31 | ₩2247.19 | ₩6630.00 | x |
| 2019-12-31 | ₩2283.44 | ₩6630.00 | x |
| 2020-12-31 | ₩1880.10 | ₩6630.00 | x |
| 2021-12-31 | ₩2106.64 | ₩6630.00 | x |
| 2022-12-31 | ₩2205.06 | ₩6630.00 | x |
| 2023-12-31 | ₩2619.79 | ₩6630.00 | x |
| 2024-12-31 | ₩2995.89 | ₩6630.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Osteonic Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.52%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.50%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.52x
- Recent ROE (9.52%) is above the historical average (-6.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 8.23% | 13.35% | 0.32x | 1.93x | ₩-100.74 Million |
| 2016 | 13.19% | 23.20% | 0.31x | 1.85x | ₩373.02 Million |
| 2017 | -57.15% | -49.70% | 0.29x | 3.99x | ₩-4.99 Billion |
| 2018 | -23.29% | -73.05% | 0.21x | 1.54x | ₩-9.49 Billion |
| 2019 | 1.72% | 4.47% | 0.21x | 1.81x | ₩-2.40 Billion |
| 2020 | -22.16% | -42.65% | 0.20x | 2.61x | ₩-7.81 Billion |
| 2021 | -8.03% | -18.28% | 0.24x | 1.81x | ₩-6.40 Billion |
| 2022 | 2.29% | 4.21% | 0.32x | 1.69x | ₩-2.81 Billion |
| 2023 | 7.05% | 13.16% | 0.39x | 1.38x | ₩-1.53 Billion |
| 2024 | 9.52% | 16.50% | 0.38x | 1.52x | ₩-282.84 Million |
Industry Comparison
This section compares Osteonic Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Osteonic Co. Ltd (226400) | ₩63.89 Billion | 8.23% | 0.50x | $72.72 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |